Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Discussions in Diabetes

Steven Edelman, MD and Robert Henry, MD explain the clinical characteristics that would lead to the use of a DPP-4 inhibitor versus a GLP-1 receptor agonist. They discuss the drugs’ different effects on weight and how patients’ duration of...